Literature DB >> 19229234

Should idiopathic short stature be treated with growth hormone?

Martin O Savage1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19229234     DOI： 10.1038/ncpendmet1074

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  9 in total

Review 1.  hGH for short stature: ethical issues raised by expanded access.

Authors:  David B Allen; Norman Fost
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

Review 2.  Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.

Authors:  Martin O Savage; Kenneth M Attie; Alessia David; Louise A Metherell; Adrian J L Clark; Cecilia Camacho-Hübner
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-07

Review 3.  Idiopathic short stature: management and growth hormone treatment.

Authors:  J M Wit; E O Reiter; J L Ross; P H Saenger; M O Savage; A D Rogol; P Cohen
Journal:  Growth Horm IGF Res       Date:  2008-02-21       Impact factor: 2.372

Review 4.  Idiopathic short stature: definition, epidemiology, and diagnostic evaluation.

Authors:  J M Wit; P E Clayton; A D Rogol; M O Savage; P H Saenger; P Cohen
Journal:  Growth Horm IGF Res       Date:  2008-01-07       Impact factor: 2.372

5.  Towards a consensus on the definition of idiopathic short stature.

Authors:  M B Ranke
Journal:  Horm Res       Date:  1996

6.  An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.

Authors:  A David; C Camacho-Hübner; A Bhangoo; S J Rose; F Miraki-Moud; S A Akker; G E Butler; S Ten; P E Clayton; A J L Clark; M O Savage; L A Metherell
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

7.  Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators.

Authors:  L T Rekers-Mombarg; G G Massa; J M Wit; A M Matranga; J M Buckler; O Butenandt; J L Chaussain; H Frisch; E Leiberman; R Yturriaga; D Aarskog; P G Chatelain; M Colle; C Dacou-Voutetakis; H A Delemarre-van de Waal; F Girard; J J Gosen; U Irle; M Jansen; R Jean; J C Job; M L Kaar; F Kollemann; H L Lenko; J J Waelkens
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

8.  Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Authors:  P Cohen; A D Rogol; C L Deal; P Saenger; E O Reiter; J L Ross; S D Chernausek; M O Savage; J M Wit
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

9.  High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature.

Authors:  G A Kamp; J J J Waelkens; S M P F de Muinck Keizer-Schrama; H A Delemarre-Van de Waal; L Verhoeven-Wind; A H Zwinderman; J M Wit
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791
  9 in total
  3 in total

1.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

Review 2.  Emerging options in growth hormone therapy: an update.

Authors:  Stephen F Kemp; J Paul Frindik
Journal:  Drug Des Devel Ther       Date:  2011-08-30       Impact factor: 4.162

3.  Associations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients' and Parents' Perspectives.

Authors:  Julia Hannah Quitmann; Monika Bullinger; Rachel Sommer; Anja Christine Rohenkohl; Neuza Maria Bernardino Da Silva
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.